Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank57
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-36.15%
↑ 80% vs avg
Percentile
P57
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-176.76%
Historical baseline
PeriodValue
2025-36.15%
2024-42.01%
2023-41.65%
2022-13.96%
2021-155.81%
2020-324.18%
2019-188.34%
201898.84%
201735.63%
2016-1100.00%